Plandaí Biotechnology, Inc.
OTC: PLPL0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Roger Baylis-Duffield
- Employees
- 180
- Headquarters
- London, United Kingdom
- IPO year
- 1995
- Market cap
- $448.9K
- Website
- https://www.plandaibiotech.com
Loading PLPL…
Loading profile data…Frequently asked questions about PLPL
What does Plandaí Biotechnology, Inc. (PLPL) do?
Plandaí Biotechnology, Inc. specializes in developing distinctive botanical extracts intended for the nutriceutical and pharmaceutical industries. A primary focus is the development of its Phytofare Catechin Complex, an extract originating from green tea cultivated at the Senteeko Tea Estate in Mpumalanga, South Africa. The company is also advan...
Where does PLPL trade?
Plandaí Biotechnology, Inc. (PLPL) trades on the Other OTC.
What sector is PLPL in?
Plandaí Biotechnology, Inc. (PLPL) operates in the Financial Services sector, specifically in the Shell Companies industry.
Who is the CEO of Plandaí Biotechnology, Inc.?
Roger Baylis-Duffield is the chief executive officer of Plandaí Biotechnology, Inc. (PLPL).
Where is Plandaí Biotechnology, Inc. headquartered?
Plandaí Biotechnology, Inc. is headquartered in United Kingdom.
Does PLPL pay a dividend?
Plandaí Biotechnology, Inc. (PLPL) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PLPL go public?
Plandaí Biotechnology, Inc. (PLPL) completed its initial public offering in 1995.